An Herbal Medicine, Yukgunja-Tang is more Effective in a Type of Functional Dyspepsia Categorized by Facial Shape Diagnosis: A Placebo-Controlled, Double-Blind, Randomized Trial

Table 4

Change rate of TDS scale, SDS scale, VAS for overall dyspeptic symptoms, NDI-K, FD-QoL questionnaire, SQDQ, and proportion of responders.

Change rate of variables/Group	Gallbladder body	Bladder body	Placebo	P value
	(n = 32)	(n = 32)	(n = 32)
TDS scale	0.53 (0.38)	0.61 (0.31)	0.32 (0.54)	0.038
SDS scale	0.55 (0.36)	0.57 (0.43)	0.34 (0.72)	0.163
VAS for overall dyspeptic symptoms	0.43 (0.25)	0.48 (0.38)	0.41 (0.28)	0.692
NDI-K	0.57 (0.35)	0.61 (0.42)	0.44 (0.49)	0.274
FD-QoL questionnaire	0.58 (0.40)	0.64 (0.31)	0.19 (2.20)	0.338
SQDQ	0.36 (0.35)	0.44 (0.33)	0.34 (0.36)	0.457
Proportion of responders (%)	87.1	78.1	74.2	0.431

TDS: Total Dyspepsia Symptom; SDS: Single Dyspepsia Symptom; VAS: Visual Analogue Scale; NDI-K: Nepean Dyspepsia Index-Korean Version; FD-QoL: Functional Dyspepsia-Related Quality of Life; SQDQ: Spleen Qi Deficiency Questionnaire.
Both gallbladder and bladder body groups are treatment groups.
Change rate is defined as the value obtained by subtracting the value of 8 weeks from the value of baseline and dividing it by the value of baseline.
Values were analyzed by Pearson's chi-squared test for categorical variables and one way-ANOVA for continuous variables.
Continuous variables are presented as mean (standard deviation).
P value < 0.05 is regarded as statistically significant.